J Cell Biol 2 July 2018
Demographic, clinical, and surgical data, including age, gender, pre-surgical BMI, type of surgery performed, baseline and nadir weight, comorbidities at baseline and during follow-up, as well as details of arGLP-1 (duration and dosing), were obtained
In clinical trials, Tirzepatide has been administered for up to 52 weeks, with studies extending up to 72 weeks
Semaglutide or tirzepatide may be appropriate if you: Have a body mass index (BMI) in the range qualifying for medical weight management Are committed to lifestyle changes (diet, physical activity, behavior) Do not have contraindications such as certain pancreatic or gallbladder disorders Have no allergies to the medications or excipients These drugs are not recommended in pregnancy, while breastfeeding, or in people with certain medical conditions unless cleared by a physician
(PubMed) Pilar Valdecantos M, Prieto-Hontoria PL, Pardo V, et al
The others are approved for type 2 diabetes only, but several are used off label for obesity such as Ozempic , which has become a buzz word in popular culture